Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation

Journal of Clinical Investigation

Volumn 115, Issue 2, 2005, Pages 247-257

  Baluk, Peter ^a   Tammela, Tuomas ^b   Ator, Erin ^a   Lyubynska, Natalya ^a   Achen, Marc G ^c   Hicklin, Daniel J ^d   Jeltsch, Michael ^b   Petrova, Tatiana V ^b   Pytowski, Bronislaw ^d   Stacker, Steven A ^c   Ylä Herttuala, Seppo ^e   Jackson, David G ^f   Alitalo, Kari ^b   McDonald, Donald M ^a,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d ELI LILLY AND COMPANY   (United States)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DNA; OXYTETRACYCLINE; RNA; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 3; ENDOTHELIAL CELL GROWTH FACTOR;

ADENOVIRUS; AIRWAY OBSTRUCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSDUCTION; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHEDEMA; MOUSE; MYCOPLASMA PULMONIS; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; BACTERIAL INFECTION; BRONCHUS; C3H MOUSE; CHRONIC DISEASE; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG EDEMA; LYMPH NODE; METABOLISM; MICROBIOLOGY; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; PATHOLOGY; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; VASCULARIZATION;

ADENOVIRIDAE; AIRWAY OBSTRUCTION; ANIMALS; BRONCHI; CHRONIC DISEASE; DENDRITIC CELLS; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION; HYPERPLASIA; INFLAMMATION; LYMPH NODES; LYMPHATIC VESSELS; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C3H; MYCOPLASMA INFECTIONS; MYCOPLASMA PULMONIS; NEOVASCULARIZATION, PATHOLOGIC; NEUTROPHILS; PULMONARY EDEMA; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 20144369085     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200522037     Document Type: Article

References (53)

1. Wiggs, B.R., Bosken, C., Pare, P.D., James, A., and Hogg, J.C. 1992. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 145:1251-1258.
2. Wilson, J. 2000. The bronchial microcirculation in asthma. Clin. Exp. Allergy. 30:51-53.
3. Pullinger, B.D., and Florey, H.W. 1937. Proliferation of lymphatics in inflammation. J. Pathol. Bact. 45:157-170.
4. Jussila, L., and Alitalo, K. 2002. Vascular growth factors and lymphangiogenesis. Physiol. Rev. 82:673-700.
5. Saaristo, A., et al. 2002. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J. 16:1041-1049.
6. Rissanen, T.T., et al. 2003. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ. Res. 92:1098-1106.
7. Karkkainen, M.J., et al. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat. Immunol. 5:74-80.
8. Saaristo, A., et al. 2002. Lymphangiogenic gene therapy with minimal blood vascular side effects. J. Exp. Med. 196:719-730.
9. Byzova, T.V., et al. 2002. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood. 99:4434-4442.
10. Nagy, J.A., et al. 2002. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196:1497-1506.
11. Cao, R., et al. 2004. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell. 6:333-345.
12. Rockson, S.G. 2001. Lymphedema. Am. J. Med. 110:288-295.
13. Bowden, J.J., Schoeb, T.R., Lindsey, J.R., and McDonald, D.M. 1994. Dexamethasone and oxytetracycline reverse the potentiation of neurogenic inflammation in airways of rats with Mycoplasma pulmonis infection. Am. J. Respir. Crit. Care Med. 150:1391-1401.
14. Thurston, G., Maas, K., LaBarbara, A., and McDonald, D.M. 2000. Microvascular remodeling in chronic airway inflammation in mice. Clin. Exp. Pharm. Physiol. 27:836-841.
15. Clark, E., and Clark, E. 1937. Observations on living mammalian lymphatic capillaries-their relation to the blood vessels. Am. J. Anat. 60:253-298.
16. Yoffey, J., and Courtice, F. 1970. Lymphatics, lymph and the lymphomyeloid complex. Academic Press. New York, New York, USA/London, United Kingdom. 942 pp.
17. McDonald, D.M. 2001. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am. J. Respir. Crit. Care Med. 164:S39-S45.
18. Ezaki, T., et al. 2001. Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol. 158:2043-2055.
19. Thurston, G., Murphy, T.J., Baluk, P., Lindsey, J.R., and McDonald, D.M. 1998. Angiogenesis in mice with chronic airway inflammation: strain-dependent differences. Am. J. Pathol. 153:1099-1112.
20. Gerhardt, H., et al. 2003. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161:1163-1177.
21. Lohela, M., Saaristo, A., Veikkola, T., and Alitalo, K. 2003. Lymphangiogenic growth factors, receptors and therapies. Thromb. Haemost. 90:167-184.
22. Luttun, A., et al. 2002. Revascularization of ischemic tissues by P1GF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8:831-840.
23. Prewett, M., et al. 1999. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res. 59:5209-5218.
24. Pytowski, B., et al. 2005. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J. Natl. Cancer Inst. 97:14-21.
25. Stacker, S.A., et al. 1999. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J. Biol. Chem. 274:32127-32136.
26. Cartner, S.C., Simecka, J.W., Lindsey, J.R., Cassell, G.H., and Davis, J.K. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138-4142.
27. Oliver, G., and Detmar, M. 2002. The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature. Genes Dev. 16:773-783.
28. Jackson, D.G. 2003. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc. Med. 13:1-7.
29. Clark, E., and Clark, E. 1932. Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit's ear. Am. J. Anat. 51:49-87.
30. Collin, H.B. 1971. The fine structure of growing corneal lymphatic vessels. J. Pathol. 104:99-113.
31. Junghans, B.M., and Collin, H.B. 1989. Limbal lymphangiogenesis after corneal injury: an autoradiographic study. Curr. Eye Res. 8:91-100.
32. Makinen, T., et al. 2001. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7:199-205.
33. Cursiefen, C., et al. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113:1040-1050. doi:10.1172/JCI200420465.
34. Geleff, S., Schoppmann, S.F., and Oberhuber, G. 2003. Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch. 442:231-237.
35. Kerjaschki, D., et al. 2004. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15:603-612.
36. Ozawa, C.R., et al. 2004. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 113:516-527. doi:10.1172/JCI200418420.
37. Hamrah, P., Chen, L., Zhang, Q., and Dana, M.R. 2003. Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am. J. Pathol. 163:57-68.
38. Banchereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.
39. Randolph, G.J. 2001. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators. Semin. Immunol. 13:267-274.
40. Qu, P., Ji, R.C., and Kato, S. 2003. Histochemical analysis of lymphatic endothelial cells in the pancreas of non-obese diabetic mice. J. Anat. 203:523-530.
41. Faulkner, C.B., et al. 1995. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease. Infect. Immun. 63:4084-4090.
42. Ristimaki, A., Narko, K., Enholm, B., Joukov, V., and Alitalo, K. 1998. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J. Biol. Chem. 273:8413-8418.
43. Casley-Smith, J.R., Clodius, L., and Foldi, M. 1977. Experimental blood vascular and lymphatic occlusion in the rabbit ear and the effect of benzopyrones. Arzneimittelforschung. 27:379-382.
44. Chen, L., et al. 2004. Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat. Med. 10:813-815.
45. Hoshino, M., Nakamura, Y., and Hamid, Q.A. 2001. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. J. Allergy Clin. Immunol. 107:1034-1038.
46. Hardy, R.D., et al. 2001. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect. Immun. 69:3869-3876.
47. Chu, H.W., Honour, J.M., Rawlinson, C.A., Harbeck, R.J., and Martin, R.J. 2003. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect. Immun. 71:1520-1526.
48. Benjamin, L.E. 2000. The controls of microvascular survival. Cancer Metastasis Rev. 19:75-81.
49. He, Y., et al. 2002. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J. Natl. Cancer Inst. 94:819-825.
50. Laitinen, M., et al. 1998. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum. Gene Ther. 9:1481-1486.
51. Enholm, B., et al. 2001. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ. Res. 88:623-629.
52. Inai, T., et al. 2004. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestranons, regression of tumor vessels, and appearance of basement membrane ghosts. Am. J. Pathol. 165:35-52.
53. Prevo, R., Banerji, S., Ferguson, D.J., Clasper, S., and Jackson, D.G. 2001. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. J. Biol. Chem. 276:19420-19430.